BOSTON, MA - 11/17/2017

Newly published studies & European Guidelines recognize new test for the assessment of preterm birth risk in symptomatic patients

Parsagen Diagnostics, Inc. today announced the publication of its first multi-center US clinical trial, alongside other important studies demonstrating the clinical utility of the company’s flagship product: the PartoSure™ test.

 

BOSTON, MA - 03/13/2017

Parsagen Diagnostics pledges fundraising match to March of Dimes

Parsagen Diagnostics, Inc. is a proud March of Dimes sponsor and they are helping fundraising efforts be even more impactful this year.  This week they are incenting participants to raise money by matching up to $15,000 of March for Babies donations in Massachusetts, Vermont and New Hampshire until March 20th only.

 

BOSTON, MA - 04/15/2016

Parsagen Diagnostics donates $15,000 to March of Dimes

Parsagen Diagnostics, Inc. was looking for a way to incent fundraisers and they found it.  During a one- week period they promised donors if they raised $15,000, then Parsagen Diagnostics would match their efforts and donate $15,000 to the March of Dimes themselves.  The match was a huge success resulting in an extra $30,000 to help fight premature birth.

 

WALTHAM, MA - 05/27/2015

Massachusetts Life Sciences Center announces new round of Accelerator Program Loans

The Massachusetts Life Sciences Center (MLSC), a quasi-public agency charged with implementing the state’s 10-year, $1-billion Life Sciences Initiative, announced today the awarding of $3 million in Accelerator Program loans to 3 early-stage life sciences companies, including Parsagen Diagnostics, Inc.